Figure 1. Cumulative incidence of primary end point and acute coronary syndrome between vasodilator group and no vasodilator group.

Composite outcome of cardiac death, acute coronary syndrome, and new‐onset arrhythmia before (A) and after (C) propensity score matching; acute coronary syndrome before (B) and after (D) propensity score matching.